Bugra Ayan
Overview
Explore the profile of Bugra Ayan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
646
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Umur E, Bulut S, Yigit P, Bayrak E, Arkan Y, Arslan F, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200293
The disease of osteoporosis is characterized by impaired bone structure and an increased risk of fractures. There is a significant impact of cytokines and hormones on bone homeostasis and the...
2.
Skeletal muscle-on-a-chip in microgravity as a platform for regeneration modeling and drug screening
Kim S, Ayan B, Shayan M, Rando T, Huang N
Stem Cell Reports
. 2024 Jul;
19(8):1061-1073.
PMID: 39059375
Microgravity has been shown to lead to both muscle atrophy and impaired muscle regeneration. The purpose was to study the efficacy of microgravity to model impaired muscle regeneration in an...
3.
Khanna A, Ayan B, Undieh A, Yang Y, Huang N
J Mol Cell Cardiol
. 2022 May;
169:13-27.
PMID: 35569213
Three-dimensional (3D) bioprinting of cellular or biological components are an emerging field to develop tissue structures that mimic the spatial, mechanochemical and temporal characteristics of cardiovascular tissues. 3D multi-cellular and...
4.
Hu C, Ayan B, Chiang G, Chan A, Rando T, Huang N
Bioengineering (Basel)
. 2022 Jan;
9(1).
PMID: 35049746
Volumetric muscle loss (VML) is associated with irreversibly impaired muscle function due to traumatic injury. Experimental approaches to treat VML include the delivery of basic fibroblast growth factor (bFGF) or...
5.
Orhan K, Bayrakdar I, Celik O, Ayan B, Polat E
Imaging Sci Dent
. 2021 Oct;
51(3):337.
PMID: 34621663
No abstract available.
6.
Agarwal T, Fortunato G, Hann S, Ayan B, Vajanthri K, Presutti D, et al.
Mater Sci Eng C Mater Biol Appl
. 2021 May;
124:112057.
PMID: 33947551
Annually increasing incidence of cardiac-related disorders and cardiac tissue's minimal regenerative capacity have motivated the researchers to explore effective therapeutic strategies. In the recent years, bioprinting technologies have witnessed a...
7.
Dey M, Ayan B, Yurieva M, Unutmaz D, Ozbolat I
Adv Biol (Weinh)
. 2021 Apr;
5(7):e2100090.
PMID: 33857356
Metastatic breast cancer is one of the deadliest forms of malignancy, primarily driven by its characteristic micro-environment comprising cancer cells interacting with stromal components. These interactions induce genetic and metabolic...
8.
Zhou K, Dey M, Ayan B, Zhang Z, Ozbolat V, Kim M, et al.
Biomed Mater
. 2021 Feb;
PMID: 33571984
Three-dimensional (3D) printing technology is increasingly being employed in biochemical as well as clinical applications and more importantly in fabrication of microfluidic devices. However, the microfluidic community mainly relies on...
9.
Ozbolat V, Dey M, Ayan B, Povilianskas A, Demirel M, Ozbolat I
ACS Biomater Sci Eng
. 2021 Jan;
4(2):682-693.
PMID: 33418756
Despite extensive use of polydimethylsiloxane (PDMS) in medical applications, such as lab-on-a-chip or tissue/organ-on-a-chip devices, point-of-care devices, and biological machines, the manufacturing of PDMS devices is limited to soft-lithography and...
10.
Ayan B, Celik N, Zhang Z, Zhou K, Kim M, Banerjee D, et al.
Commun Phys
. 2020 Nov;
3.
PMID: 33251340
Bioprinting of cellular aggregates, such as tissue spheroids, to form three-dimensional (3D) complex-shaped arrangements, has posed a major challenge due to lack of robust, reproducible and practical bioprinting techniques. Here,...